Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 151–154 of 154 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03840239	TNT to Increase the Clinical Complete Response Rate for Distal LARC(TESS)	active not recruiting	Phase 2	98	Sun Yat-sen UniversityOTHER	1	Oct 25, 2023	clinicaltrials
NCT04304209	Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer	active not recruiting	Phase 2	195	Sun Yat-sen UniversityOTHER	1	Feb 1, 2023	clinicaltrials